When a decision to interrupt dabigatran therapy for an invasive procedure has been made for a patient with AF/AFL, we suggest that interruption begin 1-2 days before a procedure with low risk of major bleeding and 2-3 days before a procedure with an intermediate or high risk of major bleeding for eGFR is ≥80ml/min/1.73m² (Conditional Recommendation, Low Quality Evidence). The upper end of these ranges should be used if eGFR is 50-80 ml/min/1.73m², an additional day should be added for eGFR 30-50 ml/min/1.73m², and in case eGFR is found to be <30 ml/min/1.73 m², yet one more day of dabigatran withdrawal should be added (Conditional Recommendation, Low Quality Evidence)